ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
103,496.19
-0.60%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Ocular Therapeutix Inc (OCUL)

  7. Ocular Therapeutix Inc (OCUL) 뉴스

OCUL

Ocular Therapeutix (OCUL)

Ocular Therapeutix Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:OCUL
일자시간출처헤드라인심볼기업
2025/01/1721:00GlobeNewswire Inc.Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OCULOcular Therapeutix Inc
2025/01/1421:00GlobeNewswire Inc.Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDRNASDAQ:OCULOcular Therapeutix Inc
2025/01/0821:00GlobeNewswire Inc.Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference PresentationNASDAQ:OCULOcular Therapeutix Inc
2024/12/1321:00GlobeNewswire Inc.Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OCULOcular Therapeutix Inc
2024/12/1021:30GlobeNewswire Inc.Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:OCULOcular Therapeutix Inc
2024/12/0221:30GlobeNewswire Inc.Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1NASDAQ:OCULOcular Therapeutix Inc
2024/11/2721:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/11/2721:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/11/2721:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/11/2721:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/11/2621:30GlobeNewswire Inc.Ocular Therapeutix™ to Participate in December Investor and Scientific ConferencesNASDAQ:OCULOcular Therapeutix Inc
2024/11/2608:42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/11/2608:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/11/2608:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/11/2607:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/11/2607:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/11/1507:49Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OCULOcular Therapeutix Inc
2024/11/1423:37Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:OCULOcular Therapeutix Inc
2024/11/1421:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OCULOcular Therapeutix Inc
2024/11/1421:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCULOcular Therapeutix Inc
2024/11/1421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCULOcular Therapeutix Inc
2024/11/1421:00GlobeNewswire Inc.Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business HighlightsNASDAQ:OCULOcular Therapeutix Inc
2024/11/1321:30GlobeNewswire Inc.Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIVNASDAQ:OCULOcular Therapeutix Inc
2024/11/1221:30GlobeNewswire Inc.Ocular Therapeutix™ Appoints Namrata Saroj, OD, as Chief Business OfficerNASDAQ:OCULOcular Therapeutix Inc
2024/11/0904:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OCULOcular Therapeutix Inc
2024/11/0621:30GlobeNewswire Inc.Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024NASDAQ:OCULOcular Therapeutix Inc
2024/10/2307:06Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OCULOcular Therapeutix Inc
2024/10/1705:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OCULOcular Therapeutix Inc
2024/10/1520:30GlobeNewswire Inc.Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMDNASDAQ:OCULOcular Therapeutix Inc
2024/10/1006:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCULOcular Therapeutix Inc
 검색 관련기사 보기:NASDAQ:OCUL

최근 히스토리

AMEX
XLF
Financial Select Sector
PM
XAUUSD
Gold vs US Dollar
USOTC
BASFY
BASF (QX)
CCOM
US30
US 30
COIN
ADAUSD
Cardano
NYSE
XOM
Exxon Mobil
CCOM
US100
US Tech 100
FX
USDJPY
US Dollar vs Yen
CCOM
SILVER
SILVER
COIN
DOGEUSD
Dogecoin
USI
USTECH100
US Tech 100
COIN
XRPUSD
Ripple
FX
USDGBP
US Dollar vs Sterling
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유